Remedy has published its latest financial results, reporting a “profitable first quarter” as it prepares to launch its next title, Control Resonant.
This marks the first quarter since former Electronic Arts VP Jean-Charles Gaudechon was appointed CEO, a role he assumed effective March 1, 2026.
The numbers
- Revenue: €13.1 million (down 1.9%)
- Operating profit: €1 million, down 23% compared to €1.3 million for the same quarter last year
The highlights
Despite decreases in overall revenue and operating profit, Remedy’s game portfolio remained stable.
Game sales and royalties rose, driven by stronger publishing for Control, increased royalties from Alan Wake 2, and revenue from FBC: Firebreak subscription agreements.
The developer reported that Control, launched in 2019, achieved year-over-year sales growth driven by increased promotions and higher visibility from Resonant. Control has now sold over six million lifetime copies.
Royalties for Alan Wake 2 increased after both it and Alan Wake Remastered became available on Amazon’s Luna service, generating “platform-deal royalties.”
Although FBC: Firebreak did not meet Remedy’s internal targets, the developer confirmed it will “remain live and playable” and that “upkeeping the infrastructure will not incur significant costs.”
Development fees declined in the first quarter but still represented more than half of total revenue, generated by Resonant and the Max Payne 1 and 2 remakes.
Remedy’s main focus in the first quarter was the marketing campaign for Resonant, which launches later this year.
The developer also highlighted that the game supports eight audio languages, including Chinese and Brazilian Portuguese, making it “the most localised Remedy game to date.”
“After assuming the role of CEO and getting to know the company and our teams, my belief in Remedy’s vision and future only continues to be reinforced,” said CEO Jean-Charles Gaudechon.
“Remedy has a pivotal year ahead, and we are off to a good start. Our first quarter was profitable, our games on the market performed to our expectations and we’re making steady progress with our development projects. Delivering a high-quality Control Resonant with a successful launch is our top priority and we are on track for our 2026 launch.”
Gaudechon continued: “In a volatile and crowded market, Remedy’s signature approach to storytelling and gameplay, our proprietary Northlight engine, the Remedy Connected Universe and a unique voice in the industry make Remedy’s games stand out in a way that’s impossible to replicate.
“In parallel, we have a studio with world-class talent and a track record in delivering multi-award-winning titles at structurally more efficient budgets compared to many of our peers. The studio is the right size for the ambitions ahead of us, and our focus now is on execution.”
“Remedy’s DNA is a product of an ambitious creative culture that has been carefully built over three decades. Protecting and reinforcing that culture and letting it compound is ultimately how we create value and is a key priority for me as the CEO.”
